GL1X · GenesisL1 explorer

Research workbench

Structure of cetuximab Fab mutant in complex with EGFR extracellular domain

Analyse Structure of cetuximab Fab mutant in complex with EGFR extracellular domain in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6ARU
Type
protein
Length
1,031 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Epidermal growth factor receptor; Cetuximab mutant light CHAIN,UNCHARACTERIZED protein…
EC
2.7.10.1
UniProt
P00533, Q8TCD0, P0DOX5
Ligands
NAG, MAN, BMA
Pockets
11 · best druggability 0.51

Structure

x-ray diffraction · 3 distinct chains · 10% helix, 37% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEpidermal growth factor receptor (EC 2.7.10.1)protein60912% helix, 26% strandP00533
BCetuximab mutant light CHAIN,UNCHARACTERIZED proteinprotein2106% helix, 50% strandQ8TCD0
CCetuximab mutant heavy chain Fab FRAGMENT,IMMUNOGLOBULIN gamma-1 heavy chainprotein2127% helix, 52% strandP0DOX5

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 7 copies · chains A, C
  • MAN · alpha-D-mannopyranose · sugar · 5 copies · chains A
  • BMA · beta-D-mannopyranose · sugar · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12010.510.7736empty
22120.460.7429empty
31600.460.7633empty
41550.440.7525empty
51200.420.7617empty

Interfaces

3 interfaces between chains.

  • B–C · 1709 Ų buried · 19 hydrogen bonds · protein-protein
  • A–C · 631 Ų buried · 12 hydrogen bonds · protein-protein
  • A–B · 395 Ų buried · 4 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 28 disulfide, 5 glycan (disulfide, N-glycosylation).

Compared structures

  • 6ARU · Structure of Cetuximab Fab mutant in complex with EGFR extracellular domain · the same entry in another collection · chain A against A, TM-score 1.00
  • P00533 · AlphaFold monomer V2.0 prediction for epidermal growth factor receptor (P00533) · a predicted model of the same protein · chain A against A, TM-score 0.76

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.